{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:47:40Z","timestamp":1762325260655},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T00:00:00Z","timestamp":1648166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T00:00:00Z","timestamp":1648166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1038\/s41440-022-00890-8","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T15:16:35Z","timestamp":1648221395000},"page":"758-768","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diuretics versus others for long-term clinical outcomes as first-line antihypertensive medications: analysis of national real-world database"],"prefix":"10.1038","volume":"45","author":[{"given":"Hack-Lyoung","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doyeon","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Hyeok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Hyun","family":"Ihm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungha","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Chul","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,25]]},"reference":[{"key":"890_CR1","first-page":"e139","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association. Circulation. 2020;141:e139\u2013e596.","journal-title":"Circulation."},{"key":"890_CR2","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903\u201313.","journal-title":"Lancet."},{"key":"890_CR3","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317:703\u201313.","DOI":"10.1136\/bmj.317.7160.703"},{"key":"890_CR4","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837\u201353.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"890_CR5","first-page":"e426","volume":"138","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138:e426\u2013e483.","journal-title":"Circulation"},{"key":"890_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40885-019-0124-x","volume":"25","author":"HY Lee","year":"2019","unstructured":"Lee HY, Shin J, Kim GH, Park S, Ihm SH, Kim HC, et al. 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertens. 2019;25:20.","journal-title":"Clin Hypertens"},{"key":"890_CR7","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u2013104.","journal-title":"Eur Heart J"},{"key":"890_CR8","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"890_CR9","doi-asserted-by":"crossref","unstructured":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981\u201397.","DOI":"10.1001\/jama.288.23.2981"},{"key":"890_CR10","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1016\/j.jacc.2017.11.004","volume":"71","author":"DM Reboussin","year":"2018","unstructured":"Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, et al. Systematic review for the 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:2176\u201398.","journal-title":"J Am Coll Cardiol"},{"key":"890_CR11","first-page":"Cd008276","volume":"8","author":"VM Musini","year":"2017","unstructured":"Musini VM, Gueyffier F, Puil L, Salzwedel DM, Wright JM. Pharmacotherapy for hypertension in adults aged 18 to 59 years. Cochrane Database Syst Rev. 2017;8:Cd008276.","journal-title":"Cochrane Database Syst Rev"},{"key":"890_CR12","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/S0140-6736(19)32317-7","volume":"394","author":"MA Suchard","year":"2019","unstructured":"Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394:1816\u201326.","journal-title":"Lancet."},{"key":"890_CR13","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1046\/j.1523-1755.2002.00200.x","volume":"61","author":"AB Chapman","year":"2002","unstructured":"Chapman AB, Schwartz GL, Boerwinkle E, Turner ST. Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. Kidney Int. 2002;61:1047\u201355.","journal-title":"Kidney Int."},{"key":"890_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-141","volume":"11","author":"LM Brewster","year":"2013","unstructured":"Brewster LM, Seedat YK. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and \u03b2-adrenergic blockers? A systematic review. BMC Med. 2013;11:141.","journal-title":"BMC Med"},{"key":"890_CR15","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1370\/afm.708","volume":"5","author":"IU Park","year":"2007","unstructured":"Park IU, Taylor AL. Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review. Ann Fam Med. 2007;5:444\u201352.","journal-title":"Ann Fam Med"},{"key":"890_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4070\/kcj.2020.0171","volume":"50","author":"EK Choi","year":"2020","unstructured":"Choi EK. Cardiovascular research using the Korean National Health Information Database. Korean Circ J. 2020;50:754\u201372.","journal-title":"Korean Circ J"},{"key":"890_CR17","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1056\/NEJMoa1412168","volume":"372","author":"S Bangalore","year":"2015","unstructured":"Bangalore S, Guo Y, Samadashvili Z, Blecker S, Xu J, Hannan EL. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med. 2015;372:1213\u201322.","journal-title":"N Engl J Med"},{"key":"890_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/00004872-198710000-00009","volume":"5","author":"L Wilhelmsen","year":"1987","unstructured":"Wilhelmsen L, Berglund G, Elmfeldt D, Fitzsimons T, Holzgreve H, Hosie J, et al. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens. 1987;5:561\u201372.","journal-title":"J Hypertens"},{"key":"890_CR19","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1001\/jama.1988.03720130040027","volume":"259","author":"J Wikstrand","year":"1988","unstructured":"Wikstrand J, Warnold I, Olsson G, Tuomilehto J, Elmfeldt D, Berglund G. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. JAMA. 1988;259:1976\u201382.","journal-title":"JAMA."},{"key":"890_CR20","doi-asserted-by":"publisher","first-page":"e1921618","DOI":"10.1001\/jamanetworkopen.2019.21618","volume":"3","author":"J Wei","year":"2020","unstructured":"Wei J, Galaviz KI, Kowalski AJ, Magee MJ, Haw JS, Narayan KMV, et al. Comparison of cardiovascular events among users of different classes of antihypertension medications: a systematic review and network meta-analysis. JAMA Net Open. 2020;3:e1921618.","journal-title":"JAMA Net Open."},{"key":"890_CR21","doi-asserted-by":"publisher","first-page":"b1665","DOI":"10.1136\/bmj.b1665","volume":"338","author":"MR Law","year":"2009","unstructured":"Law MR, Morris JK, Wald NJ. Use of blood pressure-lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.","journal-title":"BMJ."},{"key":"890_CR22","first-page":"25","volume":"161","author":"JM Wright","year":"1999","unstructured":"Wright JM, Lee CH, Chambers GK. Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? CMAJ. 1999;161:25\u201332.","journal-title":"CMAJ."},{"key":"890_CR23","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","volume":"289","author":"BM Psaty","year":"2003","unstructured":"Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003;289:2534\u201344.","journal-title":"JAMA."},{"key":"890_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3904\/kjim.2016.195","volume":"33","author":"YH Lee","year":"2018","unstructured":"Lee YH. An overview of meta-analysis for clinicians. Korean J Intern Med. 2018;33:277\u201383.","journal-title":"Korean J Intern Med"},{"key":"890_CR25","doi-asserted-by":"publisher","first-page":"e000788","DOI":"10.1136\/openhrt-2018-000788","volume":"5","author":"AJ Camm","year":"2018","unstructured":"Camm AJ, Fox KAA. Strengths and weaknesses of \u2018real-world\u2019 studies involving non-vitamin K antagonist oral anticoagulants. Open Heart. 2018;5:e000788.","journal-title":"Open Heart"},{"key":"890_CR26","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/NEJM199304013281303","volume":"328","author":"BJ Materson","year":"1993","unstructured":"Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993;328:914\u201321.","journal-title":"N Engl J Med"},{"key":"890_CR27","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.107.704023","volume":"118","author":"JA Johnson","year":"2008","unstructured":"Johnson JA. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. Circulation. 2008;118:1383\u201393.","journal-title":"Circulation."},{"key":"890_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3317\/jraas.2006.003","volume":"7","author":"CM Ferrario","year":"2006","unstructured":"Ferrario CM. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotensin Aldosterone Syst. 2006;7:3\u201314.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"890_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145\u201353.","journal-title":"N Engl J Med"},{"key":"890_CR30","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","volume":"359","author":"B Dahl\u00f6f","year":"2002","unstructured":"Dahl\u00f6f B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995\u20131003.","journal-title":"Lancet."},{"key":"890_CR31","doi-asserted-by":"publisher","first-page":"11A","DOI":"10.1016\/S0002-9149(01)02322-0","volume":"89","author":"P Sleight","year":"2002","unstructured":"Sleight P. Angiotensin II and trials of cardiovascular outcomes. Am J Cardiol. 2002;89:11A\u201316A. discussion 16A-17A","journal-title":"Am J Cardiol"},{"key":"890_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40885-021-00166-2","volume":"27","author":"HC Kim","year":"2021","unstructured":"Kim HC, Cho SMJ, Lee H, Lee HH, Baek J, Heo JE. Korea hypertension fact sheet 2020: analysis of nationwide population-based data. Clin Hypertens. 2021;27:8.","journal-title":"Clin Hypertens"},{"key":"890_CR33","doi-asserted-by":"publisher","first-page":"169s","DOI":"10.1378\/chest.129.1_suppl.169S","volume":"129","author":"PV Dicpinigaitis","year":"2006","unstructured":"Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:169s\u2013173s.","journal-title":"Chest."},{"key":"890_CR34","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2174\/1381612033454531","volume":"9","author":"K Amudha","year":"2003","unstructured":"Amudha K, Wong LP, Choy AM, Lang CC. Ethnicity and drug therapy for hypertension. Curr Pharm Des. 2003;9:1691\u2013701.","journal-title":"Curr Pharm Des"},{"key":"890_CR35","first-page":"598","volume":"38","author":"AP DeFilippis","year":"2017","unstructured":"DeFilippis AP, Young R, McEvoy JW, Michos ED, Sandfort V, Kronmal RA, et al. Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort. Eur Heart J. 2017;38:598\u2013608.","journal-title":"Eur Heart J"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-00890-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-00890-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-00890-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T11:07:48Z","timestamp":1650020868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-00890-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,25]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["890"],"URL":"https:\/\/doi.org\/10.1038\/s41440-022-00890-8","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,25]]},"assertion":[{"value":"29 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}